Founded in 2023 and headquartered in Cambridge, Massachusetts, Synthpop offers an API-first, multi-agent system that combines document intelligence, payer-aware reasoning, conversational voice agents, and an orchestration layer to streamline healthcare administration. The platform integrates directly with EHR, billing, and e-prescribe systems and can automate up to 80 % of business processes such as referrals, prior authorizations, eligibility checks, claims follow-ups, and other patient-access tasks. In production, Synthpop has already processed data for more than 2 million patients and connects with eight major EHR platforms. Customers report that workflows once taking 40 minutes are now completed in under a minute at a cost roughly five times lower than traditional human labor while maintaining full compliance. The company is SOC 2-audited and HIPAA-compliant, positioning it as a secure infrastructure provider within the healthcare ecosystem. With its latest funding, Synthpop plans to expand its team, deepen product capabilities, and move into additional healthcare verticals. Total funding to date stands at $23 million.

Total raised

$23M

Funding rounds

3

Latest round

Series A

Latest activity

Feb 2026